188 related articles for article (PubMed ID: 27855170)
1. Identification of an Efficient Gene Expression Panel for Glioblastoma Classification.
Crisman TJ; Zelaya I; Laks DR; Zhao Y; Kawaguchi R; Gao F; Kornblum HI; Coppola G
PLoS One; 2016; 11(11):e0164649. PubMed ID: 27855170
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of data discretization methods to derive platform independent isoform expression signatures for multi-class tumor subtyping.
Jung S; Bi Y; Davuluri RV
BMC Genomics; 2015; 16 Suppl 11(Suppl 11):S3. PubMed ID: 26576613
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.
Wang S; Liu F; Wang Y; Fan W; Zhao H; Liu L; Cen C; Jiang X; Sun M; Han P
J Transl Med; 2019 May; 17(1):179. PubMed ID: 31138312
[TBL] [Abstract][Full Text] [Related]
6. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
[TBL] [Abstract][Full Text] [Related]
7. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
Yerukala Sathipati S; Huang HL; Ho SY
BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
[TBL] [Abstract][Full Text] [Related]
8. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
9. A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype.
Wang HY; Li JY; Liu X; Yan XY; Wang W; Wu F; Liang TY; Yang F; Hu HM; Mao HX; Liu YW; Zhang SZ
Oncotarget; 2016 Nov; 7(46):74895-74903. PubMed ID: 27713134
[TBL] [Abstract][Full Text] [Related]
10. Integrative Diffusion-Weighted Imaging and Radiogenomic Network Analysis of Glioblastoma multiforme.
Heiland DH; Simon-Gabriel CP; Demerath T; Haaker G; Pfeifer D; Kellner E; Kiselev VG; Staszewski O; Urbach H; Weyerbrock A; Mader I
Sci Rep; 2017 Mar; 7():43523. PubMed ID: 28266556
[TBL] [Abstract][Full Text] [Related]
11. A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes.
Orzan F; Pagani F; Cominelli M; Triggiani L; Calza S; De Bacco F; Medicina D; Balzarini P; Panciani PP; Liserre R; Buglione M; Fontanella MM; Medico E; Galli R; Isella C; Boccaccio C; Poliani PL;
Lab Invest; 2020 Oct; 100(10):1330-1344. PubMed ID: 32404931
[TBL] [Abstract][Full Text] [Related]
12. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time.
Liao X; Cai B; Tian B; Luo Y; Song W; Li Y
J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929
[TBL] [Abstract][Full Text] [Related]
13. Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis.
Shirahata M; Iwao-Koizumi K; Saito S; Ueno N; Oda M; Hashimoto N; Takahashi JA; Kato K
Clin Cancer Res; 2007 Dec; 13(24):7341-56. PubMed ID: 18094416
[TBL] [Abstract][Full Text] [Related]
14. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
Kim YW; Koul D; Kim SH; Lucio-Eterovic AK; Freire PR; Yao J; Wang J; Almeida JS; Aldape K; Yung WK
Neuro Oncol; 2013 Jul; 15(7):829-39. PubMed ID: 23502430
[TBL] [Abstract][Full Text] [Related]
15. Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes.
Pal S; Bi Y; Macyszyn L; Showe LC; O'Rourke DM; Davuluri RV
Nucleic Acids Res; 2014 Apr; 42(8):e64. PubMed ID: 24503249
[TBL] [Abstract][Full Text] [Related]
16. Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma.
Prasad B; Tian Y; Li X
Mol Neurobiol; 2020 Dec; 57(12):5235-5246. PubMed ID: 32875483
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis of potential core genes for glioblastoma.
Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular models of glioblastoma multiforme survival.
Piccolo SR; Frey LJ
Int J Data Min Bioinform; 2013; 7(3):245-65. PubMed ID: 23819258
[TBL] [Abstract][Full Text] [Related]
19. A robust two-gene signature for glioblastoma survival prediction.
Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
[TBL] [Abstract][Full Text] [Related]
20. Proteogenomics of glioblastoma associates molecular patterns with survival.
Yanovich-Arad G; Ofek P; Yeini E; Mardamshina M; Danilevsky A; Shomron N; Grossman R; Satchi-Fainaro R; Geiger T
Cell Rep; 2021 Mar; 34(9):108787. PubMed ID: 33657365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
